I N T R O D U C T I O N
Since the birth of neuroanatomy, it has been recognized that the nervous system exhibits a most remarkable cellular diversity (Ramón y Cajal et al. 1899; Sotelo, 2003) . Although most cells can be broadly categorized as neurons or glia, there is a dizzying array of diverse cellular morphologies within these categories, particularly for neurons. Using the classic Golgi technique for sparse labeling of random neurons, even within a relatively homogenous structure such as the cerebellum, there exists at least a dozen diff erent neuronal cell types distinguishable by cell size, location, length, and complexity of dendritic arbors or axonal projections ( Figure 11 .1). Many of the fundamental questions of neuroscience are centered on this diversity of form, and presumably function, within the nervous system. What is the purpose of this remarkable diversity? How does it arise, evolutionarily and ontologically? How does this contribute to the computational capacity of the brain? Which cell types are essential for which behaviors? And, importantly, what changes and in which cell types lead to neurological disorder? Th e purpose of this chapter is to discuss current methods with which to study these cell types within the natural context of the brain in comprehensive and high-throughput manners. Th e chapter fi rst addresses the defi nition of cell types and then the approaches for targeting them genetically. Th en it touches on the "omics"-level approaches available to investigate cell types, ending with a particular focus on the molecular characterization of cell type by transcriptome profi ling.
to cell types as well: Th e form and physiology of each cell type has been carefully tuned to its particular function in the nervous system. However, in biology, adaptation is mediated not by an architect but by gene expression. Th us, to a biologist, the phrase would be: "Physiology, function, and form follow gene expression. "
Th e brain is a biological structure, tuned by evolution to input sensory information and output behavior. Th e embodiment of evolution is the cell, but the substrate of evolution is the inherited material-the DNA. To evolve a new cell type, DNA must change to generate new genes, or alter the regulation of existing genes, to provide a set of coherent specifi cations for the new cell type. While every cell has essentially an identical copy of the genome, each cell type has to be tuned to express the set of genes required for its particular functions at appropriate levels and times. A neuron with a large elaborate dendritic arbor, like a Purkinje neuron, will need to generate more postsynaptic proteins, dendritic microtubules, and ribosomes. A fast-spiking neuron will need to express more proteins for rapid repolarization of the membranes, the buff ering intracellular calcium, or a unique set of channels. Neurons that use particular transmitters need to generate enzymes for transmitter synthesis and loading into vesicles. And all cell types will need to express a unique set of receptors to respond to the local and distal cues important for their particular functional roles in the calculus of the brain. Th erefore, while cell types may be operationally defi ned by morphology, physiology, or function, all of those unique features must be mediated by the gene expression of that cell.
Th us the molecular defi nition of cell type (Box 11.1), when comprehensive enough to be genomic, will allow a fi nal taxonomy of cells, even before the relationship between particular genes and morphology or physiology are understood. However, the classic molecular methods described in Box 11.1 are not comprehensive 
CLASSICAL APPROACHES TO THE DEFINITION OF CELL TYPES

Morphological/Anatomical
Th e earliest defi nitions of cell type were strictly morphological or anatomical (Ramón y Cajal et al. 1899) . Cells were defi ned by location and shape of the cell body, orientation and elaboration of the dendritic arbor, and the projection pattern of the axons. Th ese early descriptive studies were fundamental to understanding the basic texture of the nervous system, and early inferences from morphology regarding development, information fl ow, and computational processes of the central nervous system were surprisingly insightful. However, rigorous, comprehensive classifi cation schemes and robust quantifi cation were not the focus of these early studies. Many clear cell types are apparent from these early investigations. For example, Purkinje neurons are unambiguously distinct from other cell types. Yet other gradations made by Cajal and compatriots, such as the distinctions between cerebellar Golgi neurons of long axon and Golgi neurons of short axon are less obviously a distinct classifi cation.
Functional
Perhaps the most pragmatic manner to defi ne a cell type is functional. A cell type serves as a particular computational node within a circuit, with the ultimate purpose of all circuits in the brain being to mediate behaviors. Th us, a cell type could be defi ned by its computational role in a circuit and its ultimate infl uence on an animal's capacity for a certain behavior. Early investigations involved the physical ablation (Lashley 1930) or stimulation (Penfi eld & Rasmussen 1950) of entire regions followed by behavioral analysis, permitting connections between anatomical and functional levels of analysis. With time and technical development, the resolution of these approaches gradually progressed. Stereotactic targeting of smaller and smaller structures became practical. Excitotoxic agents permitted the ablation of cell bodies rather than traversing fi bers within a region. Pharmacological agents permitted the selective manipulation of cells expressing just a particular receptor, linking functional and molecular levels of analysis to some extent. Finally, in the modern era, genetic approaches permit cell specifi c targeting of specifi c transgenic constructs for functional manipulation of cell types (Boyden et al. 2005) , allowing for defi nitions of cells important for behavioral functions in an intact animal, ranging from sleep and memory consolidation (Rolls et al. 2011 ) and feeding (Domingos et al. 2011 ) to fear conditioning (Haubensak et al. 2010; Letzkus et al. 2011) .
Physiological
With the development of electrophysiological techniques it became possible to defi ne a cell type by a coherent and consistent set of physiological properties, such as fi ring rates and patterns, membrane capacitance, aft erhyperpolarization, and electrical response to pharmacological agents. Data collection in the early studies was typically blind to any morphological or molecular features, and there were sometimes quite surprising divergences between these diff erent levels of defi nition. In the modern era, improvements in microscopy, particularly the advent of calcium dyes and two-photon imaging, allow some combination of morphological, physiological, and molecular investigation. Th e development of transgenic mouse lines expressing GFP to molecularly defi ne cell types has also been a boon to prospective physiological analysis of cell types, especially those that are present at low frequency in a tissue.
Molecular
Finally, the development of early fl uorescent microscopic techniques and of molecular reagents such as immunohistochemistry and in situ hybridization led to the recognition that (continued) even morphologically identical neurons may have somewhat distinct molecular composition (Coons AH et al. 1941 Hyden & McEwen, 1966) ; thus methods developed permitting neurons to be classifi ed by neurotransmitter phenotype (Hillarp et al. 1966; Saito et al. 1974) , receptors for drugs or neurochemicals (Roth & Barlow 1961) , or expression of particular calcium binding proteins (Celio & Heizmann 1981; Celio & Norman 1985; Hyden & McEwen 1966) . Again, these molecular features sometimes showed direct correspondence with morphological or physiological criteria and sometimes did not, most notoriously in the case of interneurons, where the relationship between particular markers and physiology is quite complicated (Yuste 2005) .
It is also clear that there are particular molecular markers that are thought to be more indicative of a particular state of a neuron, rather than the presumably more stable trait of cell type. Th e classic example being the expression of an intermediate early gene, such as cFos, thought to correspond to a recent bolus of activity in a neuron.
Finally, although we refer to molecular approaches rather broadly here, with current technology the most scalable and comprehensive will be those based on nucleic acid, such as measurement of transcript levels in particular cell types. 
TA R G E T I N G C E L L T Y P E S F O R P R O S P E C T I V E A N A LY S I S
While early methods for studying specifi c molecules in a cell, such as immunohistochemistry, collectively allowed the study of specifi c cell types post hoc, they did not directly permit in vivo observations of the cell types of interest, nor did they provide access for experimental manipulation. However, all cellular macromolecules are either direct or indirect products of genes. Th us the cell-specifi c localization of a molecule oft en indicates the cell-specifi c expression of certain genes. Th erefore a particular gene's genomic regulatory information can be coopted to drive the expression of foreign transgenes in specifi c cell types. A variety of methods now exist for doing just this, as summarized in Box 11.2. Many of these methods are applicable across a variety of species, although this chapter focuses on applications in mice-the mammalian model organism most amenable to genetic manipulation.
While not as high-throughput as readily scalable molecular methodologies such as sequencing or microarrays, several projects have systematically generated and characterized a large number of mouse lines targeting a variety of transgenes to specifi c cell types (Gong et al. 2007; Heintz 2004; Madisen et al. 2010; Portales-Casamar et al. 2010; Smedley et al. 2011; Taniguchi et al. 2011) . Th ese various transgenes (Box 11.3) facilitate the direct observation and, in some cases, manipulation of the targeted cell types. Th ese techniques have been a boon to the parallel physiological, functional, and molecular characterization of the same cells.
Th ere now exist relatively effi cient means of generating targeting constructs for transgenesis that are scalable for high-throughput approaches and potentially automation (Gong et al. 2010; Poser et al. 2008) . However, the rate-limiting step will remain to be the actual genesis and husbandry of the mouse lines. For some reagents, such as BAC transgenics, there is some potential for multiplexing constructs in vivo into a single locus, stably inherited, with independent regulation ( Figure 11 .2 ), although this could improve effi ciency to only a limited extent. 
The Limitations of Genomic Information as a Method for Targeting Cell Types
GENETIC TOOLS TO TARGET SPECIFIC CELL TYPES
Genomes contain regulatory sequences, such as promoters, enhancers, and repressors, that collectively direct the expression of the surrounding genes-oft en with exquisite temporal and spatial selectivity, or in response to particular cellular states such as sustained neuronal depolarization. Promoters and enhancers are both thought to be elements that increase the expression of the adjacent gene in appropriate contexts, while repressors are elements that suppress the expression of the gene in inappropriate contexts. Promoters are found at the start site of transcription, while enhancers can be found nearly anywhere, including in introns, or even many kilobases from the closest exons. Th e current model is that the activity of these regulatory sequences is mediated by the presence of transcription factor binding sites and corresponding epigenetic modifi cations. While there are clear examples of genes in which these elements have been studied to a high degree of detail (Johansson et al. 2002; Oberdick et al. 1990) , for the vast majority of genes these features are inferred from sequence of epigenetic marks (Muers, 2011; Myers et al. 2011) but are functionally uncharacterized. Regardless, these genomic regions can be coopted to drive the expression of particular transgenes.
Transgenesis
Transgenesis is the insertion of a distant or even exogenous gene into a new genomic context. In many species, including mouse, this can be accomplished by the injection of DNA fragments containing the gene into a fertilized oocyte (Gordon et al. 1980; Jaenisch 1976; Palmiter & Brinster 1986 ). With some low but experimentally tractable frequency, this DNA will be integrated into the oocyte's genomic DNA at one or more random locations. Th e fragments typically integrate into tandem repeated copies, oft en hundreds of copies in length (Chandler et al. 2007; Palmiter & Brinster 1986) . If the DNA integrates early enough in development to contribute to the germline, mice derived from these oocytes can transmit this transgenic locus to their progeny, establishing a transgenic line. Th e random locus of integration of the transgene is both a strength and a weakness. If the transgenes, by chance, land in a locus containing a cell specifi c promoter, these transgenes will demonstrate specifi c and heritable celltype -specifi c expression patterns. However, most frequently the injected fragment of DNA will contain a small (0.5-to 5-kb) promoter or enhancer upstream of the transgene. Depending on the locus of integration, this small regulatory element may be suffi cient to direct cell-specifi c expression in some mouse lines, such as in the examples of the PCP2 promoter (Oberdick et al. 1990 ) and Nestin enhancers (Johansson et al. 2002) . In other cases, the locus of integration interacts with the promoter to generate experimentally useful (but irreproducible) patterns of expression. For example, the small and fairly ubiquitous neuronal promoter Th y-1 was utilized to generate a range of transgenic lines, each having a heritable pattern of expression in selective subsets of neurons (Feng et al. 2000) .
Pros:
• Faster and cheaper than knockins • Less sophisticated molecular skills needed to generate construct than BAC transgenesis • Higher copy number can lead to high transgene expression Cons:
• Locus of integration eff ects more common than BACs • Retargeting the same cell type diffi cult in some cases (continued)
• Transgenerational silencing • Unintended disruption of a random gene at the locus of integration
B A C T R A N S G E N E S I S
Th ere are two primary limitations of small promoters in transgenesis. First, for many genes (and therefore many cell types), the appropriate promoters and enhancers regions for directing cell specifi c expression have not been characterized. Second, those promoters that are characterized are oft en strongly infl uenced by locus of integration eff ects. BAC transgenesis was developed to circumvent these diffi culties (Yang et al. 1997) . Bacterial Artifi cial Chromosomes (BACs) are large 100-to 200-kb fragments of mouse or human genomic DNA, maintained in bacteria. As these originally served as a mechanism to fragment genomes into manageable sizes for genome sequencing projects, large libraries of BACs exist, tiling essentially the entire mouse genome. Th ese fragments are thought to be large enough to contain most if not all of the enhancer, repressor, and promoter elements that direct cell specifi c expression of a gene, even if the individual elements are undefi ned. Th ese BACs can be readily modifi ed in bacteria, utilizing recombination-based methodologies (Gong et al. 2002; Hollenback et al. 2011; Poser et al. 2008; Yang et al. 1997) , to insert transgenes into the translation start site of cell-specifi c "driver" genes. Th e modifi ed BAC is then utilized for transgenesis, creating a novel genomic context for these transgenes. Performance is dependent on the BAC utilized, but overall, BACs have been shown to accurately and reproducibly target a wide range of cell types in the CNS (Heintz 2004) .
Pros:
• Multiple copies can insert (higher potential expression level than knockins). Greater accuracy (less locus of integration eff ects than small promoters).
• Speed (more rapid to generate than knockins).
• Little to no transgenerational silencing.
• BACs are large enough to provide suffi cient insulation from adjacent sequence, whether that is genomic sequence or even other BACs. Th us it is possible to multiplex BACs in a manner not possible in other techniques ( Figure 11 .2 ).
Cons:
• Copy number not as high as small constructs (but higher than a knockin).
• Some locus of integration eff ects possible (less than small transgenes).
• BAC constructs require more expertise to generate.
• BACs may carry extra copies of unmodifi ed genes adjacent to driver gene and thus result in increased gene dose for these genes. Oft en these genes are expressed in unrelated cells types (or even tissue) and thus may have little consequence on the phenotypes of interest in the brain, or they may be buff ered by biological mechanisms that keep RNA levels constant even when extra copies of the gene are present. But this may need to be checked by qPCR for some experiments.
K N O C K I N S
Th ere are genes in the genome that exceed even the size of a BAC as well as known examples of enhancers that are hundreds of kilobases distant from their target genes. Th erefore even BACS may not contain all of the regulatory information necessary to recapitulate the endogenous expression pattern of a gene. Th us, in many ways, inserting a transgene directly into a particular locus by targeted homologous recombination provides the ultimate opportunity 
CONTINUED
to coopt genomic regulatory information to control the expression of an exogenous transgene. While there may be gains in accuracy for some genes, there are several subtleties to the strategy that should be mentioned. First, knockins are slower and more labor-intensive than transgenics-homologous recombination requires many extra steps and screening in embryonic stem cells and additional rounds of breeding to screen chimeras. Second, in many strategies, knocking in the transgene simultaneously knocks out one copy of the endogenous gene, meaning that all mice will be haplo-insuffi cient for the driver-a gene that may be of particular importance to the cell type of interest. (In some designs this can be overcome by careful use of bicistronic sequences such as IRES or viral 2a sequences) (Taniguchi et al. 2011) . Th ird, compared with transgenics, knockins may tend to have lower expression of the transgene, as they will be present in only a single copy rather than tandem arrays. Finally, there are several reasons that even with the nearly perfect genomic context of a knockin, the transgene may diff er in observed expression from the endogenous gene-including diff erences in transcript stability, protein stability, and translation effi ciency between the gene and the transgene.
• Accuracy and reproducibility (no unintended locus of integration eff ects).
• New technologies (TALENs and CRISPR/Cas9) improving effi ciency and applicability beyond mouse.
Cons:
• Slower and more expensive than transgenesis.* • Limited to at most one or two copies of the transgene.
• Can create haploinsuffi ciency of the driver gene.
C O M B I N AT I O N S A N D I N T E G R AT I O N S
It is worth noting that variations of these techniques exist, for inserting transgenes with small promoters (Portales-Casamar et al. 2010), or BACs (Heaney et al. 2004 ) into specifi c loci (as is the case in knockins), thus balancing some of the pros and cons of knockins. Overall, the selection of the technique depends largely on the infl uence of the relevant pros and cons on a particular individual project as well as the experience and expertise of the investigator. Also, it is worth noting that many genes in the genome are heavily regulated at the level of splicing and selection of alternative transcription start sites. Th us, the selection of one transcription start site over another in targeting by BAC or knockin could clearly infl uence the expression of a transgene regardless of which method is chosen for targeting. Th is level of complexity is largely ignored by the fi eld currently.
*While this chapter was in press, new CRISPR technologies have alleviated this issue.
for Purkinje neurons, Nestin for neural stem cells, and emerging drivers such as Aldh1L1 for astrocytes-which each have apparently good specifi city in the brain, are oft en expressed robustly in other tissues as well (Anthony & Heintz 2007; Cahoy et al. 2008; Day et al. 2007; Doyle et al. 2008; Dubois et al. 2006; Foo & Dougherty, 2013; Zhang et al. 2005) . It is also a common observation in the characterization of Cre lines that many drivers are expressed in unexpected populations during development, or even the egg, resulting in widespread early recombination. Th is highlights the need for strategies that permit additional layers of experimental control for the temporal or spatial expression of genes.
Temporal Control of Transgenic
Expression Experimentally, it is oft en important to control the time of transgene expression to prevent widespread recombination, particularly for studies of development (lineage tracing) or cell 
TRANSGENES OF NOTE
F L U O R O P H O R E S
Th e most common transgene providing anatomical access to particular cell types is the green fl uorescent protein (GFP), derived from Aequorea victoria, or its variants. Over a decade of engineering and directed evolution have resulted in variants covering a range of fl uorescence wavelengths, of which CFP, YFP, and GFP have been shown to have robust fl uorescent properties and a lack of overt toxicity in vivo. Th e other major family of fl uorescent proteins in use in laboratories is the variants of the red fl uorescent DSRed gene, originally isolated from Discosoma . Th ough frequently incredibly bright and stable, several of these, particularly the monomeric forms, have been reported to have toxicity or to aggregate in vivo (Dougherty et al. 2012b; Strack et al. 2008) . Tandem dimerized variations of this protein (tdTomato) apparently do not display these detrimental properties and have been gaining popularity both as transgenes and as the new standard reporter lines for Cre recombinase (Madisen et al. 2010) . Finally, this is quite an area of active research and new proteins with novel properties are continuously being discovered, designed, or evolved. In addition to continual modifi cations to adjust wavelengths and increase maturation, stability, and brightness, there also exist variants with photoswitchable wavelengths (Andresen et al. 2008) , new far-red variants (Dieguez-Hurtado et al. 2011; Shcherbo et al. 2009 ), variants whose wavelengths change over time (Terskikh et al. 2000; Yanushevich et al. 2003) , as well as proteins that alter fl uorescent properties in response to changes in intracellular calcium (Looger & Griesbeck, 2012; Tian et al. 2012) .
R E C O M B I N A S E S
Recombinases are proteins that recognize specifi c sequences in DNA and re-arrange or recombine the DNA in particular predictable manners. By far the most commonly used recombinase is the Cre recombinase, derived from bacteriophage. Cre canonically recognizes specifi c DNA sequences called LoxP sites. Depending on the relative orientation of the sites, Cre can be used to either excise or invert DNA fl anked by Lox P sites ("Floxed") or insert large fragments of DNA into single sites or even mediate engineered chromosomal rearrangements (Mills & Bradley, 2001; Nakatani et al. 2009; van der Weyden & Bradley, 2006) . Since the introduction of the technique, the most important adaptations have included modifi cations to optimize codon usage for mammalian systems (Shimshek et al. 2002) , the fusion with the estrogen receptor to permit tamoxifen inducible nuclear translocation (and thus recombination) (Indra et al. 1999) , the identifi cation of alternative variations of LoxP sites (Siegel et al. 2001) , and the development of split Cre reagents for recombination mediated by the intersection of expression of two separate loci (Hirrlinger et al. 2009 ).
As a distant second, the next most frequently utilized recombinase is Flpe, an optimized version of the Saccharomyces cerevisiae Flp-1 recombinase. Th is recombinase recognizes Frt sites rather than LoxP. It has also now been optimized for mammalian codon usage and thermostability (Kranz et al. 2010; Rodriguez et al. 2000) and has inducible variations available (Hunter et al. 2005) .
In addition to providing fl exibility of experimental strategies, the development of a second recombination system has opened the door to strategies that respond to particular combinations of gene expression. For example, there are now reporter mice that express GFP only aft er recombination by both Cre and Flpe (Farago et al. 2006) , allowing even more specifi c molecular defi nitions of cell type.
R E A G E N T S F O R A C T I VAT I N G A N D S I L E N C I N G C E L L T Y P E S
For neuroscientists interested in the physiological properties and functional roles of particular cell types, the development of light-activatable ion channels has been an extraordinary advance. Th ese channels combine the millisecond temporal resolution required for sophisticated and naturalistic manipulation of neurons together with all the potential for targeting of genetically encoded tools to provide extraordinary specifi city for cell type. Th e basic tool for activation, Channelrhodopsin, derived from Chlamydomonas reinhardtii , is a channel that passes cations upon stimulation by blue wavelength light. Th is allows depolarization suffi cient to trigger action potentials in neurons. For inhibition, the basic tool is Halorhodopsin, a yellow light -driven chloride pump derived from Halobacterium, that could be utilized to hyperpolarize neurons and prevent them from fi ring. Both of these tools, as well as related proteins derived from other species, have now been extensively modifi ed to adapt them to mammalian systems, increase stability, maturation, membrane localization, and provide a wider variety of wavelengths. Th e most current variants of each are recently reviewed (Chow et al. 2012; Lin, 2011) . Th ese tools have been shown to be eff ective when inserted in a cell-specifi c manner with virus (Haubensak et al. 2010; Letzkus et al. 2011) or under the control of specifi c BACs (Zhao et al. 2011a ), or Cre reporters (Madisen et al. 2010) .
Experimentally activatable G protein -coupled receptors are also now available. Examples include chimeras of vertebrate rhodopsins with the intracellular loop from a β2-adrenergic receptor allowing light activation of second messenger signaling (OptoXRs) (Airan et al. 2009 ), as well as a variety of receptors lacking endogenous mammalian ligands, such as DREADS, RASSLs, and Allostatin receptors (Masseck et al. 2011) . Th ese tools will permit the investigation of a variety of neuromodulatory and secondary messenger signaling within genetically targeted cell types.
Finally, it is worth noting a variety of tools for relatively permanently silencing neurons, including toxic transgenes (Garcia et al. 2004; Hara et al. 2001 ) and tethered toxins (Auer et al. 2010 ), now exist. While these tools lack the exquisite temporal resolution of their light-activated analogs, they are advantageous for studies requiring long-term silencing to study the behavioral consequences of the functional ablation of particular cell types.
TA G S A N D F U S I O N S ( C H I P, C L I P, T R A P, A N D S U B C E L L U L A R P R O T E O M I C S )
A variety of strategies have been developed to adapt biochemical purifi cation techniques to cell-specifi c profi ling, most notably affi nity purifi cation of RNA, DNA, protein complexes, and specifi c subcellular organelles. One example of this is the TRAP methodology for translating ribosome affi nity purifi cation . In this method a transgene that is a fusion protein of eGFP and the ribosomal protein L10a (Rpl10a) is targeted to specifi c cell types. Th is is typically done using BACs, although any of the methods in Box 11.2 could be applicable and Cre-responsive lines now exist. Because of the Rpl10a moiety, the protein is incorporated into ribosomes and is thus associated with mRNA that is undergoing translation only in the targeted cell type. Th e eGFP moiety then serves both as a fl uorescent tag for anatomical studies as well as an affi nity tag for biochemical purifi cation: mouse brains are rapidly homogenized, and the GFP-tagged ribosomes (and affi liated mRNAs) are captured with anti-GFP antibodies coupled to magnetic beads. Th e method has been shown to be eff ective across a range of cell types in the nervous system (Doyle et al. 2008) and, when coupled to microarray or RNAseq, allows a genome-wide snapshot of mRNAs in use in a particular cell. Although the method has not yet been validated with any genomic assays, the very similar Ribotag strategy utilizes an HA tag and a Cre-responsive knockin into the Rpl22 locus to capture ribosomes (Sanz et al. 2009 ).
(continued) BOX 11.3 CONTINUED Similar strategies have been applied to study the interaction of mRNAs and microRNAs to particular RNA-binding proteins using the more generic CLIP (cross-linking and immunoprecipitation) approach, utilizing either tagged versions of the protein or antibodies against the endogenous protein (Chi et al. 2009; He et al. 2012; Jensen & Darnell 2008) . Likewise any protein of interest can be expressed in a tagged form in specifi c cell populations, or under its endogenous promoter and be utilized for affi nity purifi cation followed by proteomic strategies to study protein-protein interactions and protein modifi cations in particular cell types (Bateup et al. 2008; Zhong et al. 2009 ). Tagged DNA-binding proteins can also be expressed in a cell-specifi c manner to permit cell-specifi c epigenetic approaches, such as studying the interaction of transcription factors to DNA with CHIP (chromatin immunoprecipitation) (Zhang et al. 2008) . Th is can be helpful both to study the diff erential binding patterns of the same protein in distinct cell types, or as an alternative strategy when antibodies to the endogenous protein are unavailable or ineff ective. Finally, it has been demonstrated that tags of the correct protein can permit the cell-specifi c purifi cation of entire organelles in a manner suffi cient for proteomic analysis (Heller et al. 2012; Selimi et al. 2009 ). Th is approach opens completely new avenues of investigation for cell biologists interested in the nervous system. BOX 11.3 CONTINUED function at discrete time points, such as during acquisition of a new behavior in a learning assay or aft er early development. Currently there exist several methods for integrating additional temporal regulation into genetic modifi cations. All have some utility, although there are particular advantages and disadvantages to each.
First, utilization of inducible recombinases, such as a fusion protein of Cre or Flpe together with an estrogen receptor (Cre-Ert2), can limit recombination events to a particular time window when a drug (tamoxifen) is added, avoiding recombination in early development (Danielian et al. 1998; Hunter et al. 2005) . Although Cre-Ert2 can be less effi cient than normal Cre under the same driver (S. Gong, personal communication) (Gong et al. 2007 ), this approach is becoming more widespread. Likewise, there exists a smaller set of lines utilizing tetracycline-responsive promoter and repressor elements coopted from Escherichia coli (Passman & Fishman 1994; Saez et al. 1997; Zhou et al. 2009 ). Th e advantage over Cre is reversibility, with the ability to add and then remove the drug again later to turn the gene on and back off . Th e disadvantages are reported leakiness of the system in some lines, toxicity of tTA transgene at high levels, and the lack of lines targeting a wide range of cell types compared with the number of available Cre drivers.
Second, utilizing combinations of recombinases (Farago et al. 2006 ), or split recombinases (Hirrlinger et al. 2009 ), one can design logic gates such as "and" or "or" that would require the concurrent or sequential expression of two genes in a cell type for recombination to occur (Dymecki & Kim 2007) . Th is would also permit the manipulation of cell types for which no single driver gene exists but which are unique in their expression of a particular combination of genes, with a particular timing. Th e drawbacks to this are the "allele problem" of combining three or more alleles into a single animal and the sometimes imperfect effi ciency of recombination. Th e allele problem follows from simple Mendelian rules-in attempting to combine three or more alleles utilizing heterozygous breedings, only a small fraction of the progeny generated will have the correct combination of alleles to be experimentally useful. Th us these approaches may be particularly amenable to multiplexing transgenic approaches ( Figure 11 .2 ) (Dougherty et al. 2012b) . Still, even multiplexing may be stymied by imperfect effi ciency of recombination-it is a common observation that even with accurate expression of recombinase, recombination may not occur in all cells. Th is is likely to be a function, in part, of the level of recombinase expression and, in part, of the accessibility and structure of the targeted region in the genome. Regardless, these ineffi ciencies would be estimated to be multiplicative when dealing with strategies requiring combinations of recombinases.
Finally, there is the powerful combination of Cre reagents with lentiviral and adenoviral constructs. Th ere are two variations of this approach-a virus with a fl oxed transgene can be injected into a mouse line with cell specifi c Cre expression or a virus expressing Cre can injected into a mouse line with a fl oxed gene or transgene in the genome. Th ere are several advantages to these approaches. First, the time of injection permits temporal control of transgene expression, thus circumventing diffi culties with Cre lines with early expression. Second, locus of injection allows for a level of anatomical selectivity, or the intersection of region and cell type, in a manner that genomic drivers alone may not permit. Th ird, the strong promoters available in the virus may permit more robust transgene expression than most endogenous promoters, whether knockin or BAC. Th is is a particularly important benefi t for transgenes such as channelrhodopsins that require high levels of expression for effi cacy.
Nongenetic Methods of Targeting
Cell Types Overall, most of these methods generally rely on genomic information for targeting and thus are reliant on a molecular defi nition of cell types. However, alternatives do exist. For example, injecting retrogradely labeling fl uorescent dyes into the spinal cord can permit the sorting and profi ling of corticospinal upper motor neurons , thus using an anatomical defi nition of cell type to harvest molecular information. As long as perfect drivers do not exist for all cell types, clever use of retrogradely integrating reagents, including an interesting set of engineered rabies viruses , could also permit the expression of transgenes in a cell-specifi c manner based on projection patterns and anatomical connections.
C E L L O M I C S : H I G H -T H R O U G H P U T A N D C O M P R E H E N S I V E C H A R A C T E R I Z AT I O N O F C E L L T Y P E S
While the act of transgenesis and animal husbandry remain low-throughput, once they are targeted there now exist several related methods for high-throughput characterization of the molecular properties of specifi c cell types.
Th ese -omics and -omics-like approaches can be organized roughly by the tradition of cell-type defi nition (Box 11.1) that they best inform. Of these, the molecular approaches are the most readily scalable, although several technologies currently enhancing the throughput of other approaches should be mentioned.
Morphological "Anat-omics"
Over the last decade, several complimentary projects have undertaken eff orts to characterize the expression of hundreds or thousands of genes in the genome within the mouse brain and embryo (Easterday et al. 2003; Geschwind et al. 2001; Gray et al. 2004; Heintz 2004; Jones et al. 2009; Lein et al. 2007; Magdaleno et al. 2006; Shimogori et al. 2010; Visel et al. 2004) . Although, as a general rule, quality is oft en inversely proportional to throughput, these resources have transformed the manner in which we analyze expression studies and demonstrated the potential of automation and informatics even when applied to techniques with components that are not as inherently scalable as sequencing or microarrays.
Th ese eff orts collectively have generated a new encyclopedia of knowledge about gene expression, and we cannot overemphasize the importance of this work. However, there are several important caveats to consider in examining these sources of data (Jones et al. 2009 ). First, null results for a given gene (lack of any expression in the brain) should be viewed with extreme caution, as these assays are typically executed with little optimization for any given gene and each technique has a diff erent threshold of detection and dynamic range. RNA for genes with no measurable expression by in situ hybridization can be detected by other methods (Dougherty et al. 2010; Lee et al. 2008) . Second, in most cases only a single isoform per gene has been assayed; thus our knowledge is likely incomplete for the other products of a given gene. Finally, these approaches are not inherently quantitative, and time of development for the enzymatic reactions may be variable. With these techniques, comparison across diff erent experiments regarding the relative strength of gene expression can be misleading. Nonetheless, these resources provide an essential baseline analysis for the anatomy of gene expression in the nervous system. It is also worth noting there are methodological advances that may improve some of these shortcomings.
One important advancement that may serve to increase the throughput of anatomical studies using genetically encoding fl uorophores is the direct coupling of tissue sectioning with automation of fl uorescent microscopy and data acquisition (Ragan et al. 2012) . Scanning the brain in real time as it is sectioned removes many intermediate steps that may result in experimental variability (such as development with enzymatic reagents) and provides data that are more readily quantifi able, with the exquisite morphological detail available from high-resolution two-photon imaging and the capacity for three-dimensional reconstruction. If the eventual cost of these systems permits it, future genome-wide eff orts to characterize fl uorescent molecule expression may bypass expensive, time-consuming, and nonquantitative enzymatic detection and amplifi cation steps. Likewise, advances in imaging may remove the need for sectioning altogether (Chung & Deisseroth, 2013) .
Another interesting advance has been the combination of multiple fl uorophores in single animals both in targeted strategies (Dougherty et al. 2012b; Feng et al. 2000; Shuen et al. 2008 ) and the "Brainbow" approach for a fl uorescent variation of a high-throughput Golgi-like labeling (Weissman et al. 2011) . Th ese approaches, particularly in combination with digitization eff orts, have the potential to permit some parallelization and automation of the analysis of morphological studies.
Finally, one emerging technology proposes to adapt the throughput of sequencing technology to study connectivity (Oyibo et al. 2011) . Retrogradely transported viruses, capable of genomic integration, lift unique DNA "barcodes" from the genome of one cell to into the genomes of synaptically connected cells. Potentially, sequencing of these tags from the genomes of each cell might permit the construction of an all vs. all map of connectivity of a mouse nervous system.
Physiological and Functional Cellomics
Th e mature high-throughput correlate for physiological studies would be the implantable multielectrode array. Developed over the last two decades, these arrays have permitted the simultaneous physiological assessment of tens to hundreds of individual neurons within a region. Th is advance has provided the opportunity to understand the behavior of cells in situ and in a relatively unbiased manner. A variety of important conceptual advances have been made possible by this technology. Th e understanding of the importance of neural synchrony to perceptual processing within and across regions has been strongly advanced by these studies (Miller & Wilson 2008) , as have the hypotheses regarding memory consolidation during sleep (Sutherland & McNaughton 2000) . However, aside from some recent examples utilizing these tools in clever combination with genetically encoded constructs for silencing or activating neurons (Haubensak et al. 2010; Letzkus et al. 2011) , there is little about the technique that lends itself to analysis of prospectively targeted cell types.
Th is niche is being fi lled now by the development of genetic indicators of neural activity-especially genetically coded calcium indicators (Looger & Griesbeck 2012; Tian et al. 2012) . Although early indicators have existed since the 1980s, only recently have proteins been developed with properties suffi cient to merit their widespread adoption. Th e parallel development of enhanced capacity for in vivo imaging, notably multiphoton microscopy and derivatives, has facilitated the adoption of these technologies. Especially now with the advent of multicolor genetically encoded dyes (Zhao et al. 2011b) , the potential begins to exist to study the physiological interactions between genetically targeted cell types in awake and behaving animals. In the future, this will permit descriptive correlational studies between the behavior of neurons and the behavior of animals that will allow some inferences as to the fi nal functional role of particular cell types. However, by their very nature, behavioral analyses are going to remain relatively low-throughput methods as compared with molecular approaches.
Molecular Cellomics
Epigenomics Between the DNA and the transcription of RNA lies the epigenome. Although, in classical genetics, it had a somewhat diff erent defi nition (Waddington 2012) , epigenetics has currently come to be defi ned as the suite of modifi cations occurring to the DNA molecule itself (methylation, hydroxymethylation) or associated histones (methylation, acetylation, etc.), or the presence of other DNA binding proteins that appear to correspond to changes in gene expression (Goldberg et al. 2007 ). Whether these changes should be considered causes or corollaries of gene expression is currently unclear. Th eir accurate assessment and interpretation is an area of very active investigation (Maunakea et al. 2010) .
Current technologies for assessing epigenetic state have been moving from hybridization based (CHIP-Chip) assays to sequencing-based approaches (Chip-Seq, MRE-Seq, Methyl-Seq) (Laird 2010) . Th ese technologies share the common feature of using an affi nity reagent or enzymatic reaction (bi-sulfi te sequencing) to capture epigenetically modifi ed DNA, or epigenetic marks on proteins cross-linked to DNA, followed by sequencing to identify the approximate or exact sites of modifi cations (Harris et al. 2010) .
To date, several projects, notably ENCODE/ modENCODE, have conducted surveys across tissues to examine tissue-specifi c patterns of epigenetic modifi cation (Muers 2011; Myers et al. 2011) . Despite the fact that these methods are DNA-based and thus amenable to working with small amounts of starting material, surprisingly little of the work has focused at the level of individual cell types with the notable exception of the work that discovered DNA hydroxymethylation in mammalian cells via examination of Purkinje cell nuclei in the brain (Kriaucionis & Heintz 2009 ). As an intermediary between the DNA and transcription, many of the changes apparent from the transcriptomics ought to be refl ected in any epigenetic investigation of cell type, and direct comparisons of transcription of the epigenome may help deconvolute the meaning of many of the epigenetic marks in real in vivo contexts. Th is will likely be an area of active investigation in the next few years: technology exists for purifi cation of nuclei of specifi c cell types (Kriaucionis & Heintz 2009 ), and many epigenetic assays are scalable and applicable to small amounts of material.
Proteomics/Metabolomics
If epigenomics is the study of what comes between the RNA and the DNA, then proteomics is the study of what comes aft er RNA. Nearly any substance present in a cell is in some manner the consequence of the expression of a particular gene. Most proteins will be coded for directly by a particular RNA, while many small molecules (metabolites) and modifi cations of larger proteins are the consequence of the expression of particular enzymes.
RNA expression, while necessary for the generation of many proteins, is not suffi cient. Th e RNA must be translated-a process regulated extensively and in a transcript-dependent manner. By the best estimates we have available, RNA levels will correlate with the expression of their corresponding proteins at about 0.6 or better (Hegde et al. 2003; Kislinger et al. 2006) . Th us one could argue that knowledge of protein levels directly is more important to the prediction of cell behavior and function than RNA levels alone. Proteomics also gives additional information about the post-translational modifi cations upon the products of genes. Many, if not all, proteins are regulated by extensive post-translational modifi cations such as phosphorylation, methylation, myristoylation, ubiquitination, acetylation, and many others that can profoundly alter their activity and function, and these modifi cations are impossible to predict from RNA sequence alone. Th ere are many technical challenges, however, in performing global proteomic profi ling. Given their size, proteins are typically digested and analyzed by mass spectrometry. To achieve profi ling coverage of the hundreds of thousands of peptides generated, multidimensional separation strategies are used. Although eff ective, such strategies usually require 10 to 20 hours of analysis time and therefore impose signifi cant limitations on throughput. Moreover, generally the global profi ling approach does not screen for posttranslational modifi cations or other potential protein-protein interactions that may strongly infl uence protein activity.
To more directly examine protein activity, activity-based proteomic strategies have been developed that use chemical probes engineered to react with enzymes of interest (Kam et al. 1993) . Alternatively, as another mechanism to monitor protein activity, the substrates and products of enzymes may be measured. Th is approach, known as metabolomics, aims to simultaneously measure small molecules involved in cellular pathways such as glycolysis and the Krebs cycle. By using state-of-the-art mass spectrometry technology, tens of thousands of small molecules-metabolites-can be detected within cells (Patti et al. 2012; Scalbert et al. 2009 ). While theoretically knowledge of the levels of all proteins present in a cell would predict the presence of particular metabolites, too little is known about most of these molecules. No such comprehensive relationships can be built. Only the high-level integration of data at multiple -omics levels of investigation will permit the generation of these sorts of predictive models.
Here, we have lumped together the assessment of proteins and their products largely because the technologies available for their assessment are similar. As with epigenetic investigations, little eff ort has been focused on assays of protein or metabolite levels in specifi c cell types. Here the barriers are technologicalunlike with nucleic acid, there are no readily apparent methods for amplifying proteins and metabolites, and as sensitive as these sophisticated devices have become, collecting suffi cient material of a particular type will still be limiting for many cell types in the nervous system. Furthermore, unlike nucleic acids, individual proteins will vary widely in the biochemical properties, therefore these assays are much more sensitive to handling and extraction conditions than work with DNA and RNA. Nonetheless, there are at least two interesting advancements to be highlighted in the application of proteomics to the nervous system: organellomics and in situ metabolomics.
Organellomics
Two limitations of proteomics include the need to isolate large amounts of material from specifi c cell types, and the diffi culty in detecting low abundance proteins. One possible approach to tackling this question is to focus on specifi c subcellular compartments in specifi c cell types. Th e focus on just a particular organelle or subcellular compartment (such as the synapse) should increase the relative abundance of important proteins that may be of relatively low abundance cell wide. Th e use of transgenic technologies can permit adding tags for affi nity purifi cation of specifi c organelles. For example, Selimi and colleagues tagged just the parallel fi ber synapse on Purkinje neurons by expressing a fusion of GFP to the GluRδ2 protein specifi cally in Purkinje neurons. Affi nity purifi cation of these specifi c synapses from biochemical preparations of the mouse brain permitted proteomics of this specifi c synapse in a specifi c cell type, leading to important insights into signaling within this structure in these cells (Selimi et al. 2009 ).
One could imagine parallel approaches for purifi cation of other organelles from specifi c cell types. Even existing mouse lines with GFP tagged ribosomes could be used to study differences in protein composition of ribosomes from particular cell types (Doyle et al. 2008) . Th e drawback to these approaches is that they may depend on de novo transgenesis for each cell type and biochemical optimization for each organelle of interest, but they permit more comprehensive information than would be available by any other method.
In Situ Metabolomics
One major challenge of the application of proteomics and metabolomics to the nervous system is the requirement to isolate a suffi cient number of cells in a manner that is not too disruptive to the very profi le to be studied. Any technique that involves physical dissociation of living cells from the nervous system is likely to have some eff ect on the profi le. Th erefore, new technologies that combine classic anatomical preparations with mass spectrometry are of great interest to study the in situ profi le of particular cell types. Th e nanostructure initiator mass spectrometry (NIMS) imaging technique rasters a laser across a slice of tissue on a special substrate and measures by mass spectrometry the ionized particles as they come off the tissue (Patti et al. 2010) . Currently the technique is limited in that only the most abundant products can be measured given ion suppression eff ects. Nonetheless, resolution is on the level of the individual cells, and combination with genetically labeled tissue may permit proteomic and metabolomic investigation of specifi c cell types in situ.
Transcriptome/Translatomics
Measurement of relative RNA abundances is the most inherently scalable and accessible approach to the molecular characterization of cell types. RNA, once converted to cDNA, can be amplifi ed essentially limitlessly. Compared with genomic DNA (for epigenetic applications), most RNAs are present in more than two copies per gene per cell. And a variety of robust platforms exist for profi ling RNA pools, ranging from the hybridization-based microarrays to emergent RNA-sequencing technologies. Because of these features, inputs as low as even single cells or tens of cells have successfully been utilized for measurement of gene expression by qPCR, sequencing and microarrays (Burgemeister et al. 2007; Dixon et al. 2000; Hempel et al. 2007; Islam et al. 2011; Mary et al. 2011) .
Th ese studies have shown a remarkable diversity of gene expression across cell types in the nervous system. Comparison of even very closely related cell types, such as Drd1 and Drd2 medium spiny neurons Lobo et al. 2006) or corticospinal neurons to corticostriatal neurons Schmidt et al. 2012 ) has identifi ed hundreds of transcripts that are diff erentially regulated. For more distantly related cell types, such as comparing a Purkinje cell to an astrocyte or to a cholinergic neuron of the medial habenula, there are thousands of diff erentially regulated genes (Doyle et al. 2008) , with differences so robust they violate some of the assumptions normally utilized in microarray analysis (Dougherty et al. 2010) . Indeed, one of the most striking fi ndings of these studies was that diff erent types of neurons were as specialized from one another as neurons were from glia. Genes that were particularly prone to high magnitudes of variation across cell types (high entropy) coded for classes of molecules typically found at the cell surface, such as receptors and channels, that mediate the response of particular cell types to the environment, as well as some transcription factors and calcium binding proteins (Doyle et al. 2008) .
Th ese -omics-level approaches to gene expression in particular cell types provide a wealth of information beyond the capacity of pursuit of individual laboratories. Th ese data can broadly inform both our understanding of the cells in the normal brain as well as their importance to pathological states. Continuing to capture and distribute this information is going to be an important part of any -omics level study. Unfortunately, the actual measurements are so platform-dependent that comparisons across studies are diffi cult. Nonetheless, analysis within a study can still provide novel biological insights regarding these cells in health and disease.
C U R R E N T A N D E M E R G I N G U S E S O F T R A N S C R I P T O M I C A P P R O A C H E S A N D D ATA Finding Novel Molecules Important for the Function of Particular Cell Types
Studies profi ling particular cell types have been conducted by laboratories interested in identifying novel features of these cells. Th e common fi nale of these transcriptomic studies of a particular cell type is a functional assay with one or a small number of the enriched transcripts discovered in the screen, oft en transcription factors Dougherty et al. 2012a; Lai et al. 2008; Lobo et al. 2006; Molyneaux et al. 2005) . For example, Arlotta et al. compared gene expression during development of corticospinal neurons and callosal projection neurons and identifi ed a corticospinal neuron-specifi cally expressed gene, Ctip2, that was then found to be necessary for normal development of these cells in functional assays Dougherty & Geschwind, 2005) . While this selection of a single enriched transcript is necessary when pursing labor-intensive functional studies, these same profi les could easily be mined to identify many more transcripts key to cellular function.
Prediction of the Physiological Properties of the Cell Types
A related approach is to utilize the profi les as a means to predict the physiological properties of the cell type of interest. Th is is of particular interest in the identifi cation of drug targets, such as receptors, that may have cell-specifi c expression and thus present unique therapeutic opportunities to alter the behavior of particular cell types in vivo. An example of this work was the identifi cation by Heiman et al. of a novel G protein -coupled receptor enriched in a subclass of medium spiny neurons . A separate group identifi ed from microarray data particular potassium channels that likely mediate the development of fast spiking behavior in some cortical interneurons (Okaty et al. 2009 ). Another example was the characterization of a new cell type that appears necessary to mediate much of the response to antidepressants (Schmidt et al. 2012 ). In the future, profi ling a particular, medically relevant cell type may be a powerful method to identify new drug targets for psychiatric or neurological disorders where the relevant cell types are known (Bartfai et al. 2012 ).
Characterization of Cell Types in Disease Models and Other
Manipulations As the reproducibility of cell-specifi c profi ling has improved, it has become possible to study not just the profi le of these cells in the normal state but also to conduct comparative studies of pathological conditions, such as injuries, or genetic models of human diseases. Th e ability to study the response of particular cell types to stimuli as varied as drug exposure Schmidt et al. 2012) , tumorigenesis (Dougherty et al. 2012a; Fomchenko et al. 2011) , or gene knockout and overexpression (Warner-Schmidt et al. 2012) gives us the potential to learn a great deal of new neurobiology about each of these processes at a resolution and throughput previously unavailable. With its high reproducibility (Doyle et al. 2008) , TRAP is particularly amenable to this approach, and these studies represent a large fraction of the TRAP studies currently under way.
Interpretation of Human Gene Expression Data from a Cellular
Perspective Finally, even for those investigators not conducting transcriptome profi ling in their own labs, these resources have proven very useful datasets to aid in the interpretation of other gene expression data. One recent example of this work is the comparative analysis of diff erent subclasses of glioblastoma tumors with the expression profi les of the major cell types of the brain. Th is work hinted that diff erent subtypes of glioblastoma likely had emerged from diff erent classes of normal cell types in the brain (Cahoy et al. 2008; Verhaak et al. 2010 ). Likewise, work profi ling whole human brains across regions, time, and species has suggested that many, and perhaps most, gene expression diff erences seen in these studies are really driven by diff erences in cellular composition across the samples (Kang et al. 2011; Oldham et al. 2006 Oldham et al. , 2008 . Emerging approaches are attempting to explicitly incorporate cellular information into analytical models for human data (Kuhn et al. 2011; Shen-Orr et al. 2010 , Xu & Dougherty, 2013 . Future approaches more explicitly utilizing the cellular profi les available from model organisms may lead to further improvements in the analysis and interpretation of human gene expression data. Th is is particularly important in psychiatric diseases, such as autism, where the relevant cell types are not known. If the human expression data can guide us to consistent cellular alterations, even in the context of distinct genetic or environmental causes across diff erent individuals, then treatments could be tailored to address the common cellular defi cits.
Recent work in this direction for autism is very promising (Voineagu et al. 2011 ).
Interpretation of Human Genetic Data from a Cellular Perspective
Philosophically similar is the interpretation of human genetic data from a cellular perspective. Ongoing high-throughput genetic association studies utilizing single nucleotide polymorphisms (SNPs), copy number variations, or resequencing of exomes and genomes are identifying catalogs of common and rare variants that contribute to risk of developing various diseases of the nervous system. Cell-specifi c transcript profi ling can contribute to these studies in at least two major ways.
1. If a particular cell type is already implicated in a disorder (such as dopaminergic neurons in Parkinson's disease or hypocretin neurons in narcolepsy), then cell-specifi c transcriptional profi ling can be utilized to identify candidate genes for genetic analysis in human populations. As an example, it is well documented that a subset of individuals with autism have hyperserotonemia (Lam et al. 2006) , suggesting that there may also be fundamental diff erences in the regulation of serotonin in their brains. We profi led serotonin-producing cells in the brain and identifi ed a set of transcripts enriched in these cells. Polymorphisms in two of these genes are associated with autism in humans, and mutations in one of these had the eff ect of altering serotonin levels in mouse brains as well as resulting in behaviors reminiscent of autism . Th is candidate-gene-list approach, while having merit, is going to be eclipsed in human genetics by the rapidly falling cost of genome-wide sequencing studies. However, cell-specifi c transcript profi ling can still make important contributions to the interpretation of these studies. 2. It is clear from the current studies that there are many, if not hundreds, of genetic routes to manifesting a complex psychiatric disorder like schizophrenia (Lee et al. 2012) or autism (Bill & Geschwind 2009 ). Th erefore treatment strategies focused on specifi c genetic defects will have limited applicability. However, if these defects converge at the level of particular cells, then, as noted above, the cell becomes the target for treatment. One manner in which a diverse set of genes may converge on a particular cell type is through gene expression. Th ere are two ways in which to conduct these analysesfi rst statistically: if the set of genes implicated in a human psychopathology are expressed more oft en than expected by chance in a particular cell type, the suggestion is that cell type is important to the disease process. Second, biologically: if even a single strongly implicated gene is expressed in only one cell type in the brain, then that provides extremely robust evidence for that cell type in the disorder. For example, an apparent autosomal dominant form of Tourette's syndrome was recently associated with a strongly deleterious mutation in the HDC gene in a large family (Ercan-Sencicek et al. 2010 ). As Hdc is expressed almost uniquely in histaminergic neurons in the brain, this strongly suggests that dysregulation of CNS histamine neurons can cause Tourette's syndrome. Th erefore drugs that infl uence these cells may be of use in the treatment of Tourette's syndrome, at least in this family if not more broadly (Fernandez et al. 2012) .
Finally, it is worth noting that the same cell-specifi c profi les that give the information for these analyses also simultaneously provide a list of potentially druggable molecules (receptors, kinases) that are enriched or uniquely expressed in the candidate cell types. Th is information could be essential to the design of treatments targeting these specifi c cell types (Bartfai et al. 2012; Doyle et al. 2008; Nelson et al. 2006 ).
The Grand Correlation-Assigning Putative Functions to Novel Genes In the current era, there are roughly twenty thousand protein coding genes in the genome of the mouse and approximately the same number in humans. Of these, only a subset has even been named and even fewer are the focus of at least one publication. Th us the majority of the genome remains essentially unstudied. Th ere is a great as yet untapped potential in these cell-specifi c profi ling data for putative functional categorization for novel genes. Given enough cell types and good systematic phenotypic data regarding them it may be possible from a grand correlation to infer rough functions for these unstudied or understudied genes.
For example, imagine that one were interested in identifying genes involved in the maintenance of dendrites. Currently we have measured the RNA profi les of over twenty different types of neural cells (Dalal et al. 2013; Dougherty et al. 2012a; Dougherty et al. 2013; Doyle et al. 2008; Heiman et al. 2008; Schmidt et al. 2012) . If one were to carefully measure a phenotype, such as the average dendritic area from each of these cell types, one could then look for genes whose expression is positively correlated with the phenotype as an in silico screen for genes involved in particular processes. Th e same approach could be taken for axon length, fi ring rate, nuclear size, fos expression in response to agonist, dendritic branching, or density of mitochondrial labeling. Much as webQTL permits in silico genetic investigations by only the phenotypic profi ling of a standard set of strains (Wang et al. 2003) , these profi ling data provide an additional opportunity to leverage existing information to screen for novel contributors to a phenotype of interest. We have taken initial steps in this direction by providing a browsable interface for published bacTRAP data ( http://java.bactrap.org/bactrap/ index.jsp ) (Dougherty et al. 2010) .
Likewise, if parallel measurements can be conducted on the metabolic, epigenetic, and transcriptomic levels of a suffi ciently large number of cell types, then the possibility exists for a truly grand correlation-a matrix that may permit the prediction of which epigenetic marks correspond to the production of which transcripts, and which transcripts indicate the presence of particular metabolites, and are thus related to the pathways that generate them. Th is combination of approaches-this overlapping of -omics with -omics-has the alluring potential to unlock many of the puzzles emerging from these intertwined fi elds.
The End Game of Molecular Analysis
Of the molecular -omics methods, the most readily scalable are the molecular methods based around nucleic acids (RNA and DNA). A fi nal, comprehensive taxonomy of cell types within the brain may await the moment when every cell type in the brain can be individually and comprehensively assayed for RNA expression-a goal that is not perhaps as unimaginably distant as it might seem. If the rate of decrease in sequencing costs continues at the exponential pace of the last 4 years (NHGRI, 2012), within 13 years it will be feasible to conduct RNA-seq on each of the ~100 billion neurons of a human brain, with 30 million 100-bp reads per neuron, for less than $500,000. By 15 years, it would cost $20,000. Th is all assumes that every neuron would need to be assayed, rather than just a suffi ciently large subset, to identify all extant types. Comprehensive clustering by gene expression would then permit a fi nal molecular categorization of all cell types, down to the level of individual cells.
T H E F I N A L W O R D
It is important to keep in mind, in this era of heady scientifi c acceleration, that although data generation may be high-throughput, good data interpretation is low-throughput. Careful tool development and even more careful thought will always be needed to cope with this deluge of data.
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